Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/11/17 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 05/11/17 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 05/09/17 | Current report filing |
|
33 | ||
| 05/08/17 | Current report filing |
|
5 | ||
| 04/25/17 | Current report filing |
|
25 | ||
| 04/25/17 | Current report filing |
|
7 | ||
| 04/21/17 | Definitive proxy statements |
|
37 | ||
| 04/03/17 | Prospectus filed pursuant to Rule 424(b)(5) |
|
64 | ||
| 03/31/17 | Prospectus filed pursuant to Rule 424(b)(5) |
|
14 | ||
| 03/31/17 | Current report filing |
|
40 |
